Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.

MLA

Beghetti, Maurice, et al. “Pharmacokinetic and Clinical Profile of a Novel Formulation of Bosentan in Children with Pulmonary Arterial Hypertension: The FUTURE-1 Study.” British Journal of Clinical Pharmacology, vol. 68, no. 6, Dec. 2009, pp. 948–55. EBSCOhost, https://doi.org/10.1111/j.1365-2125.2009.03532.x.

APA

Beghetti, M., Haworth, S. G., Bonnet, D., Barst, R. J., Acar, P., Fraisse, A., Ivy, D. D., Jais, X., Schulze-Neick, I., Gali, N., Morganti, A., Dingemanse, J., Kusic-Pajic, A., & Berger, R. M. F. (2009). Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study. British Journal of Clinical Pharmacology, 68(6), 948–955. https://doi.org/10.1111/j.1365-2125.2009.03532.x

Chicago

Beghetti, Maurice, Sheila G. Haworth, Damien Bonnet, Robyn J. Barst, Philippe Acar, Alain Fraisse, Dunbar D. Ivy, et al. 2009. “Pharmacokinetic and Clinical Profile of a Novel Formulation of Bosentan in Children with Pulmonary Arterial Hypertension: The FUTURE-1 Study.” British Journal of Clinical Pharmacology 68 (6): 948–55. doi:10.1111/j.1365-2125.2009.03532.x.